{"schema_version":"secwatch.filing_event.v1","accession":"0000049071-24-000037","form_type":"8-K","ticker":"HUM","cik":"0000049071","company_name":"HUMANA INC","filed_at":"2024-07-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.555728+00:00","generated_at":"2026-05-31T14:35:11.525106+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Humana Q2 GAAP EPS $5.62, Adj EPS $6.96; cuts FY GAAP guidance to ~$12.81","bullets":["Q2 GAAP EPS $5.62 vs $7.66 YoY; adjusted EPS $6.96 vs $8.94 YoY; revenue $29.54B vs $26.75B.","FY 2024 GAAP EPS guidance revised to ~$12.81 from ~$13.93; adjusted EPS guidance reaffirmed at ~$16.00.","Benefits expense ratio rose to 89.0% from 86.3% YoY due to elevated Medicare Advantage medical cost trends.","Individual Medicare Advantage annual membership growth estimate raised by 75k to ~225k (4.2% growth)."],"urls":{"canonical":"https://secwatch.observer/filing/0000049071-24-000037","json":"https://secwatch.observer/filing/0000049071-24-000037.json","markdown":"https://secwatch.observer/filing/0000049071-24-000037.md","text":"https://secwatch.observer/filing/0000049071-24-000037.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/49071/000004907124000037/0000049071-24-000037-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/49071/000004907124000037/hum-20240731.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T14:35:11.525106+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}